AQST
Aquestive Therapeutics Inc
4.70$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.6% | -8.7% | +66.8% | -32.6% | -12.4% | -26.5% | +14.7% | +28.0% | +1.6% | +11.0% | -4.3% | – | |
| – | -2.5% | -6.2% | +3.1% | -2.0% | +1.9% | -19.2% | +24.9% | -1.2% | +29.5% | -40.6% | +15.8% | – | |
| – | +3.9% | -10.1% | +103.2% | -41.5% | -19.3% | -31.0% | +7.4% | +52.5% | -13.5% | +52.9% | -10.7% | – | |
| – | -9.6% | +105.4% | -29.8% | +26.6% | -6.7% | +9.0% | -23.4% | +10.4% | -29.4% | +31.5% | -5.8% | – | |
| – | +29.3% | +11.9% | +6.2% | +6.8% | +32.0% | +19.1% | -33.4% | +20.0% | +115.2% | -66.6% | +8.3% | – | |
| – | +17.6% | +33.6% | -6.6% | +12.1% | +20.3% | +16.8% | -31.2% | +17.7% | +82.1% | -57.9% | +18.7% | – | |
| – | – | – | – | -15,172.7% | – | – | – | – | – | – | – | – | |
| – | +146.6% | +29.8% | -0.1% | +0.1% | +0.6% | +1.3% | 0.0% | -0.1% | +0.0% | -7.9% | -2.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +62.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -532.1% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.